Pause in Trading
Filed with ASX · · 1 page · English
Summary by 6ix AI
Rhythm Biosciences Limited has announced a temporary pause in trading of its securities pending further announcement.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Market Update - All End of CY24 Milestones Attained
- Strong Demand in Share Placement to Raise $3.5 million
- Receipt of Research & Development Tax Incentive
- 2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms
- Board Renewal / Composition Update
Later from Rhythm Biosciences
- RHY Acquires Genetype Genetic Risk Assessment Business
- Completion of Genetype Risk Assessment Portfolio Acquisition
- About the Genetype Acquisition
- Quarterly Activities Report and Appendix 4C - Dec24
- Genetype Commercial Integration Completion
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences